These effects are similar to the photoreceptor degeneration in the rat model of cancer-associated retinopathy produced by intravitreous administration of anti-recoverin antibodies, which suppresses recoverin functioning and thereby promotes rhodopsin phosphorylation (Ohguro et al., 1999, 2001; Maeda et al., 2001). Here, RCVRN is linked to retinal disorder.